Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Arlene Helen Sharpe, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by Arlene Sharpe and David Reardon.
Connection Strength

0.398
  1. Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma. Clin Cancer Res. 2021 01 01; 27(1):276-287.
    View in: PubMed
    Score: 0.233
  2. Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model. Cancer Immunol Res. 2016 Feb; 4(2):124-35.
    View in: PubMed
    Score: 0.164
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.